Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_431309bc8dab94a0ee0e2aa5aeacd48d |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1676 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-225 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4825 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-225 |
filingDate |
2017-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4126950c0517501d4595c1785b792e03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f35cce3d67a9a68bcd37c731d6eef55a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98fc56083b4e94ab1a3d60364306b536 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_916d7bfcafb8af409204c0e08ba69a31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abe69f43dfa72a35d759ffba4967907b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7939d97b9f97bef2ffb92c75de8a885 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b128f9616f7e0a83a22f151591aad7a3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9984b001207fb62a2957593ba3325530 |
publicationDate |
2019-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2019046456-A1 |
titleOfInvention |
Pharmaceutical bead formulations comprising dimethyl fumarate |
abstract |
The present invention provides novel pharmaceutical compositions of dimethyl fumarate. The pharmaceutical compositions of the present invention comprises a first pharmaceutical bead composition and a second pharmaceutical bead composition, wherein the first pharmaceutical bead composition is an enterically coated immediate-release composition and the second pharmaceutical bead composition is an enterically coated controlled-release composition, wherein the first pharmaceutical bead composition and the second pharmaceutical bead composition both comprise dimethyl fumarate Methods of using the pharmaceutical compositions of the present invention for treating multiple sclerosis are also included. |
priorityDate |
2016-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |